CMS Changes Accreditation Requirements For All DMEPOS Suppliers Effective January 1, 2026.

Published in Government Relations on December 12, 2025

As we shared last week, CMS finalized the DMEPOS accreditation rule change that requires Accrediting Organizations (AOs) to survey and recredential DMEPOS suppliers annually, instead of every three years. This change is outside of competitive bidding and applies to all DMEPOS suppliers as a condition of Medicare enrollment. 

VGM Group is in frequent communication with the AOs regarding the rule specifics and implementation status. The AOs confirmed they are actively engaged with CMS, having met in aggregate earlier this week, at which CMS clarified when the annual survey and reaccreditation cycle will begin. CMS also recently published a Provision Summary and Q&A document clarifying several aspects of the change, most notably: 

“Frequency of Surveys and Reaccreditation – DMEPOS suppliers have long been required to be resurveyed and reaccredited at least every 36 months (3 years). The final rule reduces the survey and reaccreditation period to at least once every 12 months. 

  • A DMEPOS supplier’s annual resurvey and reaccreditation cycle will not begin until the expiration of the supplier’s current reaccreditation 3-year cycle (if issued prior to the final rule effective date). To illustrate, suppose a supplier was initially accredited or reaccredited for a 3-year period effective June 1, 2023. For purposes of the implementation of our new annual resurvey/reaccreditation requirement – June 1, 2026, is the date: (1) its current accreditation expired; and (2) on which its annual resurvey/reaccreditation cycle begins. Accordingly, the supplier would have to be resurveyed and reaccredited at least once by June 1, 2027, again by June 1, 2028, and so forth. The dates used in this example are not meant to imply that all accreditations must be in effect for exactly 3 years. AOs may issue reaccreditation renewals prior to the expiration date of the current period. 
  • In addition, DMEPOS suppliers seeking initial accreditation for the first time on or after the effective date of this final rule must thereafter be resurveyed and reaccredited annually. If, therefore, a new supplier became initially accredited effective June 1, 2026, it would have to be resurveyed and reaccredited by June 1, 2027, and at least once every 12 months thereafter.” 

"Q6: How long will my current accreditation last? Will it be cut short by the annual survey/reaccreditation requirement? 

A: A DMEPOS supplier’s annual resurvey and reaccreditation cycle will not begin until the expiration of the supplier’s current 3-year accreditation cycle (issued prior to the final rule effective date). More information on this issue will be provided in the coming weeks. 

Q7: Will CMS still allow sampling? 

A: Sampling allows large chains to have a percentage of their locations surveyed. CMS will allow sampling moving forward. Current methodologies will be allowed to continue, and CMS will engage with stakeholders prior to making any large shifts in sampling methodology in the future."

Suppliers should contact their AO for specific questions about their current accreditation.

Find the Final Rule, CMS Fact Sheet, and other resources on VGM’s Competitive Bidding Resource Page and van Halem Group - Competitive Bidding Program

From Our Experts

Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers.